Suntem mândri de echipa de Value, Access and Public Affairs a Novartis România pentru prezentarea unei analize comprehensive privind accesul la medicamente inovatoare prin contracte cost-volum la Conferința Națională de Farmacoeconomie (CNFMS 2024), ceea ce evidențiază experiența noastră în îmbunătățirea accesului pacienților la terapii inovatoare. Felicitări Nona Delia Chiriac, Constantin Radu, Simona Predulescu, Daiana Elena Serban !👏
Thrilled to have participated in the National Pharmacoeconomy Conference (CNFMS 2024) in Poiana Brașov alongside my incredible Value, Access, and Public Affairs team from Novartis Romania. Together, we presented a comprehensive analysis on access to innovative medicines through cost-volume (CV) contracts—critical mechanisms to facilitate patient access to innovative medicine; an analysis that we've been working on for the past 10 months, using solely internal department resources and publicly available data. Many thanks for the colleagues from other companies and healthcare experts who encouraged us from the audience. After nearly a decade of using CV contracts, we are finally able to map out what is working: 95 molecules reimbursed through this mechanism. But there’s still room for improvement—88 molecules are still awaiting reimbursement since 2022. We explored the dynamics and emphasized the importance of refining the eligibility population definition and issuing process to ensure patients have timely access to life-saving therapies. Proud to be part of a team driving meaningful conversations that pave the way for better healthcare solutions in Romania! #HealthcareInnovation #Pharmacoeconomy #NovartisRomania #ValueAccessPublicAffairs #CNFMS2024